ENTITY

Deciphera Pharmaceuticals (DCPH US)

1
Analysis
Health Care • United States
Deciphera Pharmaceuticals, Inc. operates as a biotechnology company. The Company discovers and develops kinase inhibitor treatments for various type of cancer diseases including gastrointestinal, stromal tumors, advance systemic mastocytosis, gliomas, and other solid tumors. Deciphera Pharmaceuticals serves patients globally.
more
Company Event • 06 Sep 2024 21:30 • Upcoming
Add To Calendar

Q2 2024

Company Event • 10 May 2024 19:00 • Upcoming
Add To Calendar

Q1 2024

Company Event • 16 Apr 2024 23:30 • Latest

Stifel Virtual Targeted Oncology Days Conference

Company Event • 13 Mar 2024 20:00

Barclays 26th Annual Global Healthcare Conference 2024

Company Event • 12 Mar 2024 02:40

Leerink Partners Global Biopharma Conference 2024

x